Recombinant Shigella sonnei Probable intracellular septation protein A (yciB)

What is the predicted structure and function of S. sonnei intracellular septation protein A (yciB)?

Intracellular septation protein A (yciB) in S. sonnei is predicted to be involved in bacterial cell division processes. While specific structural data for S. sonnei yciB is limited, it likely contains multiple transmembrane domains typical of septation proteins. The protein is believed to participate in the formation of the septum during bacterial cell division, potentially interacting with other components of the divisome complex .

The function can be experimentally determined through:

• Homology modeling using related proteins

• Structural prediction using tools like AlphaFold or RoseTTAFold

• Complementation studies with known septation proteins in model organisms

• Localization studies using fluorescent protein fusions

How does yciB expression vary across different S. sonnei lineages?

Expression of yciB may vary across the phylogenetically diverse lineages of S. sonnei identified in recent genomic studies. Analysis of complete genome sequences from the 15 representative S. sonnei isolates shows evidence of ongoing adaptive evolution, featuring accumulation of insertion sequences, gene pseudogenisation, and structural variation . Researchers should consider:

• Performing comparative transcriptomic analysis across lineages

• Using qRT-PCR to quantify expression levels in different isolates

• Analyzing promoter regions for potential regulatory differences

• Correlating expression patterns with lineage-specific phenotypes

What is known about the regulation of yciB expression during S. sonnei infection?

The regulation of yciB during S. sonnei infection likely involves complex environmental sensing mechanisms. S. sonnei possesses sophisticated virulence mechanisms including type III secretion system (T3SS) and type VI secretion system (T6SS) . Research approaches should include:

• In vitro infection models to monitor expression during different stages

• Reporter constructs to visualize expression in real-time

• Analysis of upstream regulatory elements

• Investigation of potential regulatory cross-talk with virulence systems

What are the optimal expression systems for producing recombinant S. sonnei yciB?

For optimal expression of recombinant S. sonnei yciB, researchers should consider:

Expression system comparison:

The choice should be guided by the specific experimental goals. For structural studies requiring large amounts of protein, E. coli systems with codon optimization may be preferable. For functional studies, ensuring proper folding and post-translational modifications may be critical.

What are effective strategies for purifying recombinant yciB while maintaining its native conformation?

Purifying membrane proteins like yciB presents significant challenges. Effective strategies include:

• Detergent screening using a panel of mild, non-denaturing detergents (DDM, LMNG, etc.)

• Optimization of solubilization conditions (temperature, pH, ionic strength)

• Use of nanodiscs or amphipols to maintain native membrane environment

• Implementing gentle affinity purification techniques

• Size exclusion chromatography as a final polishing step

For functional studies, consider reconstitution into proteoliposomes following purification to maintain native-like membrane environment.

How can researchers effectively generate and characterize yciB knockout mutants in S. sonnei?

Creating and characterizing yciB knockout mutants requires careful consideration of S. sonnei's genetic manipulation challenges:

• Generation strategies:

  • CRISPR-Cas9 mediated deletion

  • Homologous recombination with antibiotic resistance markers

  • Transposon mutagenesis with site-specific targeting

• Validation approaches:

  • PCR verification of deletion

  • Western blotting to confirm protein absence

  • Whole genome sequencing to confirm clean deletion

• Phenotypic characterization:

  • Growth curve analysis under various conditions

  • Microscopy to assess cell morphology and division defects

  • Virulence assessment in cell culture and animal models

  • Antibiotic susceptibility testing, given S. sonnei's known resistance patterns

How does yciB contribute to S. sonnei antimicrobial resistance mechanisms?

S. sonnei has developed significant antimicrobial resistance, including to ciprofloxacin and fluoroquinolones, which has intensified global spread and burden . To investigate yciB's potential role:

• Compare minimum inhibitory concentrations (MICs) between wild-type and yciB knockout strains

• Analyze expression changes in yciB during antibiotic exposure

• Investigate potential interactions between yciB and known resistance mechanisms

• Perform structural studies to identify potential antibiotic binding sites

Research suggests S. sonnei resistance to fluoroquinolone is due to sequential mutations (gyrA-S83L, parC-S80I, and gyrA-D87G), while a significant relationship exists between Integron (class II) and resistance development . Understanding yciB's role in this context requires integrating genomic, transcriptomic, and functional approaches.

What is the relationship between yciB and the Type VI secretion system (T6SS) in S. sonnei virulence?

Recent studies have identified that S. sonnei encodes a Type VI secretion system (T6SS) that allows it to outcompete other Enterobacteriaceae family members, including S. flexneri and E. coli . Investigating the relationship between yciB and T6SS requires:

• Co-immunoprecipitation studies to identify physical interactions

• Transcriptomic analysis to identify co-regulation patterns

• Competition assays using wild-type and yciB mutant strains

• Microscopy to visualize potential co-localization during infection

This investigation is particularly relevant given that T6SS is a key factor in S. sonnei's increasing prevalence globally.

How does yciB function differ across the phylogenetic lineages of S. sonnei?

Recent genomic characterization reveals significant phylogenetic diversity within S. sonnei populations, with multiple lineages associated with distinct epidemiological patterns . To investigate functional differences in yciB:

• Perform comparative sequence analysis across the 15 representative lineages

• Conduct complementation studies using yciB from different lineages

• Analyze expression patterns in different genetic backgrounds

• Correlate functional differences with lineage-specific adaptations

The completed genome sequences of 15 S. sonnei isolates, representing epidemiologically relevant and phylogenetically distinct genotypes, provide valuable resources for such comparative studies .

How does S. sonnei yciB compare structurally and functionally to homologs in other Enterobacteriaceae?

Comparative analysis of yciB requires:

Structural comparison table:

Research approaches should include:

• Phylogenetic analysis to trace evolutionary history

• Structural modeling to identify conserved domains

• Complementation studies to test functional conservation

• Analysis of selection pressures using dN/dS ratios

What role might yciB play in S. sonnei's shift from developed to developing countries?

S. sonnei has shown a shifting pattern from developed to developing countries that requires explanation . The role of yciB in this epidemiological trend could be investigated by:

• Comparing yciB sequences from isolates across geographical regions

• Correlating yciB variants with virulence and transmission phenotypes

• Investigating environmental adaptations that might involve septation proteins

• Examining potential interactions with other factors contributing to S. sonnei's global emergence

This research is particularly relevant given that S. sonnei is now the second most common infectious species of shigellosis in low- and middle-income countries and the leading one in the developed world .

What are promising approaches for targeting yciB in antimicrobial development?

With increasing antimicrobial resistance in S. sonnei , novel targets are needed. For yciB-based approaches:

• Structure-based drug design leveraging computational models

• High-throughput screening for specific inhibitors

• Peptide-based inhibitors targeting essential protein-protein interactions

• CRISPR-based antimicrobials targeting the yciB gene

Any successful approach would require validation using:

• In vitro activity assays

• Cell culture infection models

• Animal models of shigellosis

• Resistance development assessment

How might systems biology approaches enhance our understanding of yciB's role in S. sonnei pathogenesis?

Systems biology offers powerful tools to contextualize yciB function:

• Genome-scale metabolic modeling to predict effects of yciB perturbation

• Protein-protein interaction networks to identify functional partners

• Multi-omics integration (genomics, transcriptomics, proteomics)

• Machine learning approaches to predict phenotypic outcomes

The genome-scale metabolic models already produced for representative S. sonnei strains provide a foundation for such systems-level investigations.